RESEARCHER PROFILE
Chadi Nabhan
← Back to University of South Carolina
C
University of South Carolina
Chadi Nabhan works in Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Acute Lymphoblastic Leukemia research, Viral-associated cancers and disorders, CNS Lymphoma Diagnosis and Treatment. Recorded institutional associations include University of South Carolina.
278Publications
5,174Citations
38H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis
2014 · 467 citationsOutcomes of COVID-19 in patients with CLL: a multicenter international experience
2020 · 305 citationsOptimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients
2017 · 229 citationsOutcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience
2016 · 193 citationsReal-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States
2018 · 165 citationsA retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era
2011 · 164 citationsChronic Lymphocytic Leukemia
2014 · 158 citationsPeripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy
2014 · 141 citationsClonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL
2017 · 133 citationsAssessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy
2020 · 117 citationsMYC‐associated and double‐hit lymphomas: A review of pathobiology, prognosis, and therapeutic approaches
2014 · 98 citationsExamination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices
2012 · 98 citationsPrevalence and characteristics of central nervous system involvement by chronic lymphocytic leukemia
2016 · 98 citationsAnalysis of very elderly (≥80 years) non‐hodgkin lymphoma: impact of functional status and co‐morbidities on outcome
2011 · 96 citationsTumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice
2019 · 90 citationsClassifying Cytogenetics in Patients with Acute Myelogenous Leukemia in Complete Remission Undergoing Allogeneic Transplantation: A Center for International Blood and Marrow Transplant Research Study
2011 · 87 citationsGray zone lymphoma with features intermediate between classical H odgkin lymphoma and diffuse large B ‐cell lymphoma: C haracteristics, outcomes, and prognostication among a large multicenter cohort
2015 · 85 citationsPhase II pilot trial of gemtuzumab ozogamicin (GO) as first line therapy in acute myeloid leukemia patients age 65 or older
2004 · 75 citationsPredictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma—a “real world” study
2017 · 70 citationsOutcomes of front‐line ibrutinib treated CLL patients excluded from landmark clinical trial
2018 · 69 citationsA Pilot Trial of Rituximab and Alemtuzumab Combination Therapy in Patients with Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)
2004 · 68 citationsDisease characteristics, treatment patterns, prognosis, outcomes and lymphoma‐related mortality in elderly follicular lymphoma in the United States
2015 · 67 citationsPredicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary Era
2015 · 63 citationsComparable outcomes in chronic lymphocytic leukaemia ( CLL ) patients treated with reduced‐dose ibrutinib: results from a multi‐centre study
2017 · 63 citationsComparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma
2015 · 61 citations
